Disability

Spinogenix Announces Enrollment is Open for its Phase 2 Clinical Trial of SPG601 in Fragile X Syndrome

U.S. FDA has granted Orphan Drug Designation to SPG601 for the Treatment of Fragile X Syndrome SPG601 is a novel…

5 months ago

Elucid Names Kelly Huang as CEO

Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis softwareBOSTON--(BUSINESS WIRE)--Elucid, a…

5 months ago

Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy

– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had…

5 months ago

Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy

– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had…

5 months ago

Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis

LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs…

5 months ago

Med-Metrix Announces the Acquisition of HRSI, Augmenting the Company’s Eligibility Management Capabilities

PARSIPPANY, N.J., July 15, 2024 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix", or the "Company"), a leading provider of technology-enabled, Revenue Cycle…

5 months ago

Guidehouse and HIMSS Partner with the Missouri DHSS on Digital Health Assessment

First of its Kind Initiative to Guide Future Improvements in Data Collection, Management, and Utilization to Enhance Efficiencies and Improve…

5 months ago

R.O.S.A. from Trusaic Optimizes Pay Equity Remediation Efforts

Game-changing PayParity® tool optimizes salary adjustments tomaximize ROI and impact on employees LOS ANGELES, July 10, 2024 /PRNewswire/ -- Trusaic's…

6 months ago

Cresilon’s Revolutionary Hemostatic Gel Technology Shows Promising Results for Treatment of Penetrating Traumatic Brain Injury in Study Performed with Walter Reed Army Institute of Research

Findings from preclinical study demonstrate potential for a field and prehospital treatment following a penetrating TBI NEW YORK, July 9,…

6 months ago

Leading Medical Claims Management provider, Medlogix, LLC Announces the Acquisition of ReviewWorks

HAMILTON, N.J., July 8, 2024 /PRNewswire/ -- Medlogix, LLC, a leading, national medical claims management solutions provider, announced today that…

6 months ago